Stathmin guides personalized therapy in oral squamous cell carcinoma

The survival benefit from docetaxel, cisplatin and 5‐fluorouracil (TPF) induction chemotherapy in oral squamous cell carcinoma (OSCC) patients is not satisfactory. Previously, we identified that stathmin, a microtubule‐destabilizing protein, is overexpressed in OSCC. Here, we further investigated it...

Descripción completa

Detalles Bibliográficos
Autores principales: Ju, Wu‐tong, Ma, Hai‐long, Zhao, Tong‐Chao, Liang, Si‐yuan, Zhu, Dong‐wang, Wang, Li‐zhen, Li, Jiang, Zhang, Zhi‐yuan, Zhou, Ge, Zhong, Lai‐ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7156844/
https://www.ncbi.nlm.nih.gov/pubmed/31994271
http://dx.doi.org/10.1111/cas.14323

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7156844/
https://www.ncbi.nlm.nih.gov/pubmed/31994271
http://dx.doi.org/10.1111/cas.14323

Ejemplares similares